Sumner KM, Masalovich S, O´Halloran A, Holst. Severity of influenza-associated hospitalisations by influenza virus type and subtype in the USA, 2010-19: a repeated cross-sectional study. Lancet Microbe. 2023 Sep 25:S2666-5247(23)00187-8. Abstract submitted by kickingbird at 1 days ago from Lancet Microbe. 2023 Sep 25:S2666-5247(23)00187-8 Background: Influenza burden varies across seasons, partly due to differences in circulating influenza virus types or subtypes. Using data from the US population-based surveillance system, Influenza Hospitalization ... Andreev K, Jones JC, Seiler P, Kandeil A, Turner J. Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Circulating Globally in 2022-2023. J Infect Dis. 2023 Sep 28:jiad418. Abstract submitted by kickingbird at 1 days ago from J Infect Dis. 2023 Sep 28:jiad418 The antiviral susceptibility of currently circulating (2022-2023) highly pathogenic avian influenza (HPAI) A(H5N1) viruses was assessed by genotypic and phenotypic approaches. The frequency of neuraminidase ... Barkhasbaatar A, Gilbert M, Fine AE, Shiilegdamba. Ecological characterization of 175 low-pathogenicity avian influenza viruses isolated from wild birds in Mongolia, 2009-2013 and 2016-2018. Vet Med Sci. 2023 Sep 28. Abstract submitted by kickingbird at 1 days ago from Vet Med Sci. 2023 Sep 28 Background: Since 2005, highly pathogenic avian influenza A H5N1 viruses have spread from Asia worldwide, infecting poultry, humans and wild birds. Subsequently, global interest in avian influenza (AI) ... Lei Y, Sun Y, Wu W, Liu H, Wang X, Shu Y, Fang S. Influenza H7N9 virus disrupts the monolayer human brain microvascular endothelial cells barrier in vitro. Virol J. 2023 Sep 29;20(1):219. Abstract submitted by kickingbird at 1 days ago from Virol J. 2023 Sep 29;20(1):219 Influenza H7N9 virus causes human infections with about 40% case fatality rate. The severe cases usually present with pneumonia; however, some present with central nervous system complications. Pneumonia ... Wang S, Zhang TH, Hu M, Tang K, Sheng L, Hong M, C. Deep mutational scanning of influenza A virus neuraminidase facilitates the identification of drug resistance mutations in vivo. mSystems. 2023 Sep 29:e0067023. Abstract submitted by kickingbird at 1 days ago from mSystems. 2023 Sep 29:e0067023 Neuraminidase (NA) is a pivotal surface enzyme and a key therapeutic target in combating the influenza A virus. Its evolution can lead to potential zoonotic transmission, seasonal epidemics, and the emergence ... | |